Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
23 September 2024
Labor & Employment Law Perspectives
President Biden Signs "Good Jobs" Executive Order and Calls for “High Labor Standards” Policy Development
On September 6, 2024, President Biden signed the Executive Order (EO) on Investing in America and Investing in American Workers, dubbed the “Good Jobs EO.”
15 November 2024
Events
Chevron’s Demise and its Impact on Health Care
Foley partner Judy Waltz, co-chair of Foley’s Health Care Practice Group, is speaking in the California Society for Healthcare Attorneys’ 2024 Fall Seminar in a panel titled “Chevron’s Demise and its Impact on Health Care” on November 15.
12 November 2024
Events
2024 NAM Manufacturing Legal Summit
The National Association of Manufacturers will be hosting its third annual Manufacturing Legal Summit on November 12-13 in Washington D.C at the Willard InterContinental. The conference is for manufacturing lawyers addressing the latest pressing challenges across the legal regulatory landscape.